Recent Posts

Archives

Categories

Servatus launches new trial into the effects of live biotherapeutics on insomnia

AdobeStock_164771711

Servatus launches new trial into the effects of live biotherapeutics on insomnia, we talk to CEO Dr Wayne Finlayson to discuss this exciting initiative.

Posted on . Updated on by Michael Lovesey

Servatus CEO Dr Wayne Finlayson discusses the company’s new human clinical trial into the link between the gut microbiome and sleep by treating patients who suffer from insomnia with live biotherapeutics

 

Posted in Newsletter March 2022

IR Department acknowledge the Traditional Owners of the land on which it operates and pays respect to Elders past, present and emerging.

Subscribe

Site Map Privacy Search
IR Department . All rights reserved. - Site by